Vifor
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Kapruvia | Difelikefalin | 2022-04-25 | 2027 | |
| Mircera | Methoxy polyethylene glycol-epoetin beta | 2007-11-14 | ||
| Tavneos | Avacopan | 2022-01-11 | 2029-2041 | |
| Velphoro | Ferric oxyhydroxide, Sucroferric oxyhydroxide | 2013-11-27 | 2028-2034 | — |
| Veltassa | Patiromer, Patiromer sorbitex | 2017-07-19 | 2024-2033 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use